Chronic conditions like hypertension (high blood pressure) and diabetes affect millions of Americans and are major contributors to heart disease, stroke, kidney failure, and other serious health problems. Access to consistent preventive care and effective management of these conditions can significantly improve health outcomes. One policy that has made a measurable difference in this area is Medicaid expansion under the Affordable Care Act (ACA). Research shows that expanding Medicaid eligibility leads to better health insurance coverage and improved control of hypertension and diabetes — especially among underserved populations.
Why Coverage Matters for Chronic Disease Management
Before discussing the data, it’s important to understand the role of health insurance in managing chronic diseases. Conditions like high blood pressure and diabetes require ongoing care — regular monitoring, medication, lifestyle counseling, and sometimes specialist treatment. Without insurance, many low-income individuals face barriers to accessing these services, leading to worse disease control, more complications, and higher long-term healthcare costs.
Medicaid expansion aimed to reduce these barriers by increasing eligibility for low-income adults. States that adopted expansion saw large declines in uninsurance rates, meaning more people gained access to primary care, preventive services, and prescription medications.
Evidence of Improved Hypertension and Diabetes Control
A major national study published in JAMA Health Forum examined health outcomes at federally qualified health centers (FQHCs) — clinics that serve low-income and medically underserved populations — in states that expanded Medicaid versus those that did not. The findings are clear: five years after expansion, states that expanded Medicaid experienced notable improvements in control of both hypertension and diabetes compared to non-expansion states.
Across nearly 19 million patients served annually by 578 expansion-state FQHCs and 368 non-expansion FQHCs, researchers found:
- A significant decline in uninsurance rates in expansion states — a nearly 9.24 percentage point drop over five years.
- Comparative improvements in hypertension control (measured as the proportion of patients with blood pressure below 140/90 mm Hg).
- Better glucose control among patients with diabetes (measured by hemoglobin A1c levels of 9% or less).
Importantly, the gains grew larger over time — suggesting that access to coverage takes time to translate into better disease management as patients establish care, receive prescriptions, and adopt long-term treatment plans.
Impact on Health Disparities
One of the most compelling aspects of these findings is the positive effect on historically underserved groups. The study showed that improvements in hypertension and glucose control were consistent among Black and Hispanic patients, groups that often face greater barriers to care and higher rates of chronic disease. Differences in outcomes tended to increase over the five-year period, indicating that Medicaid expansion can help reduce long-standing health disparities.
However, despite the progress, disparities did not disappear entirely. This suggests that while expanding insurance coverage is a powerful tool, it must be complemented by targeted investments in care quality and social supports that address deeper systemic inequalities.
Understanding the Mechanisms
So how exactly does Medicaid expansion improve control of hypertension and diabetes?
- Increased Access to Primary Care: People with Medicaid are more likely to have a regular healthcare provider and receive routine checkups, which are essential for monitoring and adjusting treatment.
- Better Access to Medications: Coverage means fewer cost barriers to essential drugs like blood pressure medications and insulin or glucose-lowering therapies.
- Preventive Services: Regular screenings and early intervention help detect issues sooner and prevent complications.
- Reduced Uninsurance: Having stable coverage encourages people to seek care they might otherwise delay due to cost.
Policy Implications and Future Directions
These findings carry important implications for policymakers, especially in states that have not yet expanded Medicaid eligibility. The evidence suggests that expansion isn’t just about increasing insurance numbers — it’s about meaningfully improving health outcomes for people with chronic conditions.
It also highlights the need for continued research and investment in healthcare systems and social support structures that help individuals manage complex conditions over the long term. Access to insurance is a critical first step, but quality care and resources that address social determinants of health are essential for sustained progress.
Conclusion
Medicaid expansion has been shown to improve control of hypertension and diabetes by reducing uninsurance, enhancing access to care, and enabling better disease management over time. These benefits are especially significant among populations that have historically faced greater health inequities. As chronic diseases continue to strain both individuals and healthcare systems, policies that increase access to consistent, preventive care can make a real difference in public health.
